It has a strong market position as every second dialysis machine used around the world is supplied by Fresenius. It generates revenues of €9bn - a threefold increase since 2014 with an impressive net income jump of 2.5 times. It generates sales of €6.5bn with net income of €750m. Results last year were strong with sales and net income increasing by 6pc, the 15th consecutive record year. As mentioned earlier, Fresenius shares fell right out of favour, falling 30pc since its yearly high of €71 a share.

Source: Irish Independent May 20, 2019 01:30 UTC